Smoking and mental illness

[1]  C. Waternaux,et al.  Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. , 2003, The American journal of psychiatry.

[2]  H. Hwu,et al.  Suggestive evidence for linkage of schizophrenia to markers at chromosome 15q13-14 in Taiwanese families. , 2001, American journal of medical genetics.

[3]  C. Pato,et al.  Evidence for linkage disequilibrium between the alpha 7-nicotinic receptor gene (CHRNA7) locus and schizophrenia in Azorean families. , 2001, American journal of medical genetics.

[4]  M. Phelan,et al.  Physical health of people with severe mental illness , 2001, BMJ : British Medical Journal.

[5]  M. Baron,et al.  Genetics of schizophrenia and the new millennium: progress and pitfalls. , 2001, American journal of human genetics.

[6]  Edward D Levin,et al.  Cognitive effects of nicotine , 2001, Biological Psychiatry.

[7]  C. Breese,et al.  The effect of nicotine and haloperidol co-treatment on nicotinic receptor levels in the rat brain. , 2001, Brain research. Molecular brain research.

[8]  C. Robert Cloninger,et al.  Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7). , 2001, American journal of medical genetics.

[9]  A. Malhotra,et al.  Impaired attention as an endophenotype for molecular genetic studies of schizophrenia. , 2001, American journal of medical genetics.

[10]  B. Rockstroh,et al.  Event-related potentials in a working-memory task in schizophrenics and controls , 2000, Schizophrenia Research.

[11]  E. Stip,et al.  Fonctions attentionnelles et mnésiques dans la schizophrénie, étude longitudinale de sujets pharmacologiquement vierges , 2000 .

[12]  E. Albuquerque,et al.  The opioid antagonist naltrexone inhibits activity and alters expression of α7 and α4β2 nicotinic receptors in hippocampal neurons: implications for smoking cessation programs , 2000, Neuropharmacology.

[13]  S. Leonard,et al.  [3H]Nicotine binding in peripheral blood cells of smokers is correlated with the number of cigarettes smoked per day , 2000, Neuropharmacology.

[14]  S Woolhandler,et al.  Smoking and mental illness: A population-based prevalence study. , 2000, JAMA.

[15]  T. Wienker,et al.  Splitting schizophrenia: periodic catatonia-susceptibility locus on chromosome 15q15. , 2000, American journal of human genetics.

[16]  C. Clark,et al.  The effect of clozapine on the speed and accuracy of information processing in schizophrenia , 2000, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[17]  D L Braff,et al.  Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. , 2000, The American journal of psychiatry.

[18]  A. C. Collins,et al.  Abnormal Regulation of High Affinity Nicotinic Receptors in Subjects with Schizophrenia , 2000, Neuropsychopharmacology.

[19]  B. Barraclough,et al.  Causes of the excess mortality of schizophrenia. , 2000, The British journal of psychiatry : the journal of mental science.

[20]  P. Riederer,et al.  Human post-mortem striatal α4β2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome , 2000, Neuroscience Letters.

[21]  J. Krystal,et al.  Comorbidity of psychiatric and substance abuse disorders , 2000 .

[22]  P. Grof,et al.  228. A genome scan using a pharmacogenetic approach indicates a susceptibility locus for BD on 15q14 , 2000, Biological Psychiatry.

[23]  R. Murray,et al.  Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families. , 2000, American journal of medical genetics.

[24]  H. Stassen,et al.  Schizophrenia and smoking: evidence for a common neurobiological basis? , 2000, American journal of medical genetics.

[25]  N. Benowitz,et al.  Non-Nicotine Pharmacotherapy for Smoking Cessation , 2000 .

[26]  C. Spencer,et al.  Bupropion , 2000, Drugs.

[27]  G. Chiara.  Role of dopamine in the behavioural actions of nicotine related to addiction. , 2000 .

[28]  J. Gault,et al.  Smoking and schizophrenia: abnormal nicotinic receptor expression. , 2000, European journal of pharmacology.

[29]  E D Levin,et al.  Development of nicotinic drug therapy for cognitive disorders. , 2000, European journal of pharmacology.

[30]  R. Freedman,et al.  Familial transmission of risk factors in the first-degree relatives of schizophrenic people , 2000, Biological Psychiatry.

[31]  M. Caron,et al.  Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter , 2000, The European journal of neuroscience.

[32]  R. Kerwin,et al.  Neuronal Nicotinic Receptors in Dementia with Lewy Bodies and Schizophrenia , 1999, Journal of neurochemistry.

[33]  O. Pomerleau,et al.  Nicotine Withdrawal and Psychiatric Symptoms in Cigarette Smokers with Schizophrenia , 1999, Neuropsychopharmacology.

[34]  N. Craddock,et al.  Chromosome Workshop: chromosomes 11, 14, and 15. , 1999, American journal of medical genetics.

[35]  K. Blennow,et al.  Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. , 1999, Neuroreport.

[36]  C. Stockmeier,et al.  Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. , 1999, The Journal of pharmacology and experimental therapeutics.

[37]  B. Potter,et al.  Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors , 1999, Neuropharmacology.

[38]  J. Foulds.  The relationship between tobacco use and mental disorders , 1999 .

[39]  D. Housman,et al.  No evidence for linkage between schizophrenia and markers at chromosome 15q13-14. , 1999, American journal of medical genetics.

[40]  R. Lukas,et al.  Antidepressants Noncompetitively Inhibit Nicotinic Acetylcholine Receptor Function , 1999, Journal of neurochemistry.

[41]  S. Siegelbaum,et al.  Presynaptic ionotropic receptors and the control of transmitter release. , 1999, Annual review of neuroscience.

[42]  S. Arneric,et al.  Neuronal nicotinic receptors : pharmacology and therapeutic opportunities , 1999 .

[43]  R. Lukas,et al.  Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine. , 1999, The Journal of pharmacology and experimental therapeutics.

[44]  H. Meltzer,et al.  The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. , 1999, Schizophrenia bulletin.

[45]  M. Geyer,et al.  Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. , 1998, The American journal of psychiatry.

[46]  L. Hernández,et al.  Clozapine-induced acetylcholine release in the rat prefrontal cortex, nucleus accumbens and striatum does not develop tolerance , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[47]  D J Healy,et al.  Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. , 1998, The American journal of psychiatry.

[48]  E. Levin,et al.  Transdermal nicotine effects on attention , 1998, Psychopharmacology.

[49]  R. Freedman,et al.  Anticipatory saccades during smooth pursuit eye movements and familial transmission of schizophrenia , 1998, Biological Psychiatry.

[50]  G. E. Fryer,et al.  A randomized trial of nortriptyline for smoking cessation. , 1998, Archives of internal medicine.

[51]  W. Honer,et al.  No evidence for linkage of the CHRNA7 gene region in Canadian schizophrenia families. , 1998, American journal of medical genetics.

[52]  J. Gault,et al.  Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). , 1998, Genomics.

[53]  A. Beaudet,et al.  Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. , 1998, Learning & memory.

[54]  A. Glassman.  Psychiatry and cigarettes. , 1998, Archives of general psychiatry.

[55]  E. Levin,et al.  Nicotinic acetylcholine involvement in cognitive function in animals , 1998, Psychopharmacology.

[56]  S. Hall,et al.  Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. , 1998, Archives of general psychiatry.

[57]  Ian P. Stolerman,et al.  Nicotine enhances sustained attention in the rat under specific task conditions , 1998, Psychopharmacology.

[58]  J. E. O'Neill,et al.  Nicotinic receptor desensitization and sensory gating deficits in schizophrenia , 1998, Biological Psychiatry.

[59]  T. Matise,et al.  NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees. , 1998, American journal of medical genetics.

[60]  C. Robert Cloninger,et al.  Further investigation of a chromosome 15 locus in schizophrenia: analysis of affected sibpairs from the NIMH Genetics Initiative. , 1998, American journal of medical genetics.

[61]  J. Kelly,et al.  Sensitization of the Mesoaccumbens Dopamine Response to Nicotine , 1998, Pharmacology Biochemistry and Behavior.

[62]  R. Freedman,et al.  Selective α7-nicotinic agonists normalize inhibition of auditory response in DBA mice , 1998, Psychopharmacology.

[63]  Jian-Zhong Guo,et al.  Glutamate and GABA Release Are Enhanced by Different Subtypes of Presynaptic Nicotinic Receptors in the Lateral Geniculate Nucleus , 1998, The Journal of Neuroscience.

[64]  R. Freedman,et al.  Improvement in Smooth Pursuit Eye Movements after Cigarette Smoking in Schizophrenic Patients , 1998, Neuropsychopharmacology.

[65]  J. Gault,et al.  Nicotinic receptors, smoking and schizophrenia. , 1998, Restorative neurology and neuroscience.

[66]  R Freedman,et al.  Schizophrenia, sensory gating, and nicotinic receptors. , 1998, Schizophrenia bulletin.

[67]  A. Beaudet,et al.  Mice Deficient in the α7 Neuronal Nicotinic Acetylcholine Receptor Lack α-Bungarotoxin Binding Sites and Hippocampal Fast Nicotinic Currents , 1997, The Journal of Neuroscience.

[68]  E. Levin.  Chronic Haloperidol Administration Does Not Block Acute Nicotine-Induced Improvements in Radial-Arm Maze Performance in the Rat , 1997, Pharmacology Biochemistry and Behavior.

[69]  E. Albuquerque,et al.  Neuronal Nicotinic Acetylcholine Receptor Activation Modulates g-Aminobutyric Acid Release from CA 1 Neurons of Rat Hippocampal Slices 1 , 1997 .

[70]  K. Kellar,et al.  Differential Regulation of Neuronal Nicotinic Receptor Binding Sites Following Chronic Nicotine Administration , 1997, Journal of neurochemistry.

[71]  P. McGuffin,et al.  Antipsychotic regulation of dopamine D1, D2 and D3 receptor mRNA , 1997, Neuropharmacology.

[72]  Robert Freedman,et al.  Comparison of the regional expression of nicotinic acetylcholine receptor α7 mRNA and [125I]‐α‐bungarotoxin binding in human postmortem brain , 1997 .

[73]  Richard Paylor,et al.  Social Interaction and Sensorimotor Gating Abnormalities in Mice Lacking Dvl1 , 1997, Cell.

[74]  Robert Freedman,et al.  Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers , 1997, Biological Psychiatry.

[75]  A. C. Collins,et al.  Effect of Smoking History on [ 3 H]nicotine Binding in Human Postmortem Brain 1 , 2022 .

[76]  A Carlsson,et al.  Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications. , 1997, Life sciences.

[77]  John P. Rice,et al.  Initial genomic scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 3, 5, 15, 16, 17, and 22. , 1997, American journal of medical genetics.

[78]  Brett A. Clementz,et al.  P50 Suppression among schizophrenia and normal comparison subjects: A methodological analysis , 1997, Biological Psychiatry.

[79]  D. Weinberger.  The biological basis of schizophrenia: new directions. , 1997, The Journal of clinical psychiatry.

[80]  S. Wonnacott,et al.  Presynaptic nicotinic ACh receptors , 1997, Trends in Neurosciences.

[81]  A. Glassman,et al.  Major depression following smoking cessation. , 1997, The American journal of psychiatry.

[82]  P. Seeman,et al.  Atypical Neuroleptics Have Low Affinity for Dopamine D2 Receptors or Are Selective for D4 Receptors , 1997, Neuropsychopharmacology.

[83]  L Kruglyak,et al.  Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[84]  D. Abrams,et al.  Development of major depressive disorder during smoking-cessation treatment. , 1996, The Journal of clinical psychiatry.

[85]  J. Meador-Woodruff,et al.  Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex. , 1996, Brain research. Molecular brain research.

[86]  A. C. Collins,et al.  Genetic Correlation of Inhibitory Gating of Hippocampal Auditory Evoked Response and α-Bungarotoxin-Binding Nicotinic Cholinergic Receptors in Inbred Mouse Strains , 1996, Neuropsychopharmacology.

[87]  Robert Freedman,et al.  Gating of auditory P50 in schizophrenics: Unique effects of clozapine , 1996, Biological Psychiatry.

[88]  S. Woods,et al.  Effects of clozapine on smoking in chronic schizophrenic outpatients. , 1995, The Journal of clinical psychiatry.

[89]  R. Freedman,et al.  Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia , 1995, Biological Psychiatry.

[90]  E. Levin,et al.  Clozapine decreases smoking in patients with chronic schizophrenia , 1995, Biological Psychiatry.

[91]  A. Wiser,et al.  Normalization of auditory physiology by cigarette smoking in schizophrenic patients. , 1993, The American journal of psychiatry.

[92]  M. Geyer,et al.  Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. , 1993, The American journal of psychiatry.

[93]  G. Gessa,et al.  Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors. , 1993, The Journal of pharmacology and experimental therapeutics.

[94]  R. W. Guillery,et al.  New views of the thalamic reticular nucleus in the adult and the developing brain , 1993, Trends in Neurosciences.

[95]  L. Olson,et al.  Alpha-bungarotoxin binding to hippocampal interneurons: immunocytochemical characterization and effects on growth factor expression , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[96]  A. Glassman.  Cigarette smoking: implications for psychiatric illness. , 1993, The American journal of psychiatry.

[97]  J. Patrick,et al.  Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[98]  R. Freedman,et al.  Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics , 1992, Biological Psychiatry.

[99]  Robert Freedman,et al.  Cholinergic gating of response to auditory stimuli in rat hippocampus , 1992, Brain Research.

[100]  A. C. Collins,et al.  Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[101]  G. Sedvall,et al.  Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. , 1992, Archives of general psychiatry.

[102]  E X Albuquerque,et al.  Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. , 1992, Molecular pharmacology.

[103]  Daniel W. Hommer,et al.  A quantitative analysis of saccades and smooth pursuit during visual pursuit tracking A comparison of schizophrenics with normals and substance abusing controls , 1992, Schizophrenia Research.

[104]  B. Clementz,et al.  Smooth pursuit ocular motor dysfunction in schizophrenia: evidence for a major gene. , 1992, The American journal of psychiatry.

[105]  A. Glassman,et al.  CIGARETTE SMOKING, MAJOR DEPRESSION, AND SCHIZOPHRENIA , 1992, Clinical neuropharmacology.

[106]  A. Brussaard,et al.  Functional contribution of neuronal AChR subunits revealed by antisense oligonucleotides. , 1991, Science.

[107]  G. Carey,et al.  Codistribution of a sensory gating deficit and schizophrenia in multi-affected families , 1991, Psychiatry Research.

[108]  R. Freedman,et al.  Ten years of studies on P50 sensory gating: A review and considerations for future studies , 1991, Schizophrenia Research.

[109]  M. Greeman,et al.  Negative effects of a smoking ban on an inpatient psychiatry service. , 1991, Hospital & community psychiatry.

[110]  Robert Freedman,et al.  Elementary neuronal dysfunctions in schizophrenia , 1991, Schizophrenia Research.

[111]  J. Helzer,et al.  Smoking, smoking cessation, and major depression. , 1990, JAMA.

[112]  J. Sweeney,et al.  Is eye movement dysfunction a biological marker for schizophrenia? A methodological review. , 1990, Psychological bulletin.

[113]  G. Gerhardt,et al.  Sensory physiology and catecholamines in schizophrenia and mania , 1990, Psychiatry Research.

[114]  Robert Freedman,et al.  Auditory sensory gating in hippocampal neurons: A model system in the rat , 1990, Biological Psychiatry.

[115]  A. C. Collins,et al.  Variation of nicotinic binding sites among inbred strains , 1989, Pharmacology, Biochemistry and Behavior.

[116]  M. Benwell,et al.  Evidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human Brain , 1988, Journal of neurochemistry.

[117]  R. Freedman,et al.  Candidate for inherited neurobiological dysfunction in schizophrenia , 1987, Somatic cell and molecular genetics.

[118]  R. Freedman,et al.  Neurophysiological assessment of sensory gating in psychiatric inpatients: Comparison between schizophrenia and other diagnoses , 1987, Biological Psychiatry.

[119]  C. Frassoni,et al.  GABA immunoreactivity in the thalamic reticular nucleus of the rat. A light and electron microscopical study , 1986, Brain Research.

[120]  A. C. Collins,et al.  Genetic analysis of nicotine-induced seizures and hippocampal nicotinic receptors in the mouse. , 1986, The Journal of pharmacology and experimental therapeutics.

[121]  A. C. Collins,et al.  Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains. , 1986, The Journal of pharmacology and experimental therapeutics.

[122]  G. Rose,et al.  Neurophysiological studies of sensory gating in rats: Effects of amphetamine, phencyclidine, and haloperidol , 1986, Biological Psychiatry.

[123]  P. Holzman.  Eye movement dysfunctions and psychosis. , 1985, International review of neurobiology.

[124]  P. Holzman,et al.  Pursuit eye movement dysfunctions in schizophrenia. Family evidence for specificity. , 1984, Archives of general psychiatry.

[125]  R Freedman,et al.  Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients. , 1983, Biological psychiatry.

[126]  P. Holzman.  Methodological Consensus in Smooth Pursuit Eye Movements: Workshop Contributions Smooth Pursuit Eye Movements in Psychopathology , 1983 .

[127]  P. Venables,et al.  INPUT DYSFUNCTION IN SCHIZOPHRENIA. , 1964, Progress in experimental personality research.

[128]  B. Maher,et al.  Progress in experimental personality research , 1964 .